The Canadian cannabis sector continues to be blazing hot over the last year, especially in the last 2 months. The following chart shows the performance of the Canadian marijuana sector in general,the Marijuana Index Canada contains a list of 10 publicly traded Canadian companies in the space, their stock prices and market caps. Just looking at this chart, there has been a parabolic rise in share price since May of this year. Most parabolic rises like this are usually followed by a correction and then a basing period before any further advances can be made. The chart does show a clear break out and passed overhead resistance, this means we are in a new bull market for cannabis stocks in Canada. We will provide an update on the American cannabis sector shortly.

On Monday cannabidiol (CBD) producers and distributors in the UK started to receive letters from the Medicines and Healthcare Products Regulatory Agency (MHRA) demanding that they cease to sell, supply, promote, advertise or process orders for CBD products within 28 days. The letters stated that CBD now satisfies the definition of a medicinal product. The revised definition will leave UK patients with no legal access to CBD.

Officials with the MHRA are due to release a statement tomorrow, Oct. 7, to clarify the position. A spokesperson from the agency released the following statement:

We have come to the opinion that products containing cannabidiol (CBD) are a medicine. Products for therapeutic use must have a medicines’ licence before they can be legally sold or supplied in the UK. Products will have to meet safety, quality and effectiveness standards to protect public health.

We have written to UK CBD stockists and manufacturers to inform them of our view. These products will require a marketing authorisation to be granted before they can be legally sold, supplied or anywhere advertised in the UK.

Individuals who use CBD for treatment should take questions to a health care professional, the MHRA said, adding, “We can provide regulatory guidance to any company who may wish to apply for a licence.”

Peter Carroll of the End our Pain campaign, a UK medical cannabis patient advocacy group, said that “we agree that there is a need for more control in the CBD market to protect people from unscrupulous suppliers and to make sure that people understand what they are taking.” But, he added, “we fear that today’s sudden move will cause huge distress to people who rely on these products. It will drive many people to look for CBD on the black market. It is a sledgehammer to crack a nut.”

This decision further complicates the status of medical cannabis in the UK. The definition of CBD, one of the main active ingredients in cannabis, as a medicinal product is in stark contrast with The Misuse of Drugs Regulations 2001 scheduling of cannabis as having “no medicinal value”. This adds another exception to the 2001 Regulations, the other being Sativex, a cannabis-extract which is available in very limited circumstances for some MS suffers.

CBD has been soaring in popularity recently as many people purchase it in a variety of forms either as an aid to relaxation, in an attempt to quit nicotine, or for a number of serious ailments and medical conditions. CBD has been linked to a number of potential medical applications with strong anecdotal evidence of its efficacy in treating epilepsy, anxiety, depression, and multiple sclerosis, among many other conditions.

GW Pharmaceuticals, producer of Sativex, released the results of its latest phase III clinical trial for Epidiolex, a liquid formulation of CBD, on September 26. The company hopes to achieve approval in Europe, but the product is still at trial stage and not available for patients. The product is in development for the treatment of a number of conditions, specifically rare pediatric epilepsy disorders including Dravet Syndrome and Lennox-Gastaut Syndrome.

It is unclear how long, or costly, the license application will be for current CBD vendors and whether any will in fact be successful. Medicinal products must meet certain standards before being granted a marketing authorization. Interestingly, the MHRA states that “proof of efficacy generally relies heavily on clinical trial evidence, and no products must be marketed pending any license application.” To date there have been some exciting but very limited trials around CBD but there is a lack of full clinical trial evidence. The process could take years, and it is unclear whether the results of the Epidiolex trials will be relevant to other CBD products or limited to a unique GW Pharmaceutical formulation.

There have been many concerns over the unregulated CBD market. Until now, companies were able to sell CBD products so long as they did not make any medical claims about the product. There were stories of companies breaching this condition as well as providing products of dubious origin and quality. Regulation and standards of some sort will likely be welcomed by the industry but there are serious concerns over the cost, time and process involved in making license applications.

The short deadline of 28 days will come as a worrying shock for the thousands using CBD. Many will question whether this very short deadline is in the best interests of patients. For the time being we simply don’t know how long it will be before patients relying on CBD will be able to legally access their medicine in the UK.

Democratic presidential nominee Hillary Clinton spoke out against legalizing marijuana in a paid speech, hacked emails from her campaign show.

During an on-stage Q & A session with Xerox’s chairman and CEO in March 2014, Clinton used Wall Street terminology to express her opposition to ending cannabis prohibition “in all senses of the word”:

URSULA BURNS: So long means thumbs up, short means thumbs down; or long means I support, short means I don’t. I’m going to start with — I’m going to give you about ten long-shorts.

SECRETARY CLINTON: Even if you could make money on a short, you can’t answer short.

URSULA BURNS: You can answer short, but you got to be careful about letting anybody else know that. They will bet against you. So legalization of pot?

SECRETARY CLINTON: Short in all senses of the word.

The excerpt comes from an internal Clinton campaign memo highlighting potentially problematic passages from her paid speeches to Goldman Sachs, General Electric, Deutsche Bank and other major corporations.

Other excerpts from the 80-page document, published by Wikileaks after a hack on Clinton campaign chairman John Podesta’s email account, show the former U.S. secretary of state admitting she is “far removed” from the struggles of the middle class, arguing that politicians need to have separate positions on issues in public and in private and supporting “open trade and open borders.”

Over the course of the past year, the Clinton campaign forcefully refused calls to release the speech transcripts from her Democratic primary opponent, U.S. Sen. Bernie Sanders, who supports legalization and has introduced legislation to end federal marijuana prohibition.

That the campaign flagged the candidate’s opposition to legalization as a potential problem demonstrates a growing understanding by political operatives that marijuana law reform is now a mainstream issue, one which is supported by a majority of Americans and a supermajority of Democratic primary voters.

While Clinton has made no secret in public appearances that she isn’t ready to endorse full legalization, she has usually framed her position as taking a wait-and-see approach, wanting to give laws like those in Colorado and other states a chance to work before she makes up her mind about ending prohibition.

The leaked Xerox excerpt, in contrast, positions her as strongly opposed to legalization.

But the remarks were made two-and-a-half years ago, just two months after legal marijuana sales began in Colorado, so it is possible that Clinton’s personal view of legalization has legitimately softened in the interim.

During the course of her presidential campaign, Clinton has highlighted support for letting states set their own cannabis policies without federal interference and has pledged to reschedule marijuana under the Controlled Substances Act if elected.

But advocates have pushed the candidate to go even further by offering a personal endorsement for the policy of legalization, arguing that doing so could help Clinton win back support from wayward millennial voters who are supporting Libertarian Party candidate Gary Johnson or Jill Stein of the Green Party, both of whom have made support for ending cannabis prohibition centerpieces of their campaigns.

The newly-leaked documents showing Clinton’s strong opposition to legalization in a private appearance, combined with comments from the candidate’s daughter Chelsea last month implying that marijuana use can lead to death, could present an added sense of urgency for Clinton to evolve on the question of ending prohibition prior to Election Day.

The following news release was issued by the Oregon Liquor Control Commission, they have provided a guide for potential entrepreneurs and businesses interested in applying for a recreational marijuana license. If you are considering opening up a marijuana business in Oregon, please reach out to us at www.investinmj.com and contact us if you need assistance in financing, marketing or setting up your commercial grow operation. We have many contacts in the industry that are very interested in helping you succeed. We can leverage out contacts with many other commercial marijuana growers to assist you, some of which may even consider a joint venture with you.

We wish you all the best in opening up a marijuana operation in Oregon, these are very exciting times but they do come with some risk, Invest In MJ is here to help you mitigate them. IMJ Admin.

State Produces Guide for Recreational Marijuana Businesses

Designed to Help Navigate State and Local Government Requirements

November 20, 2015

Portland, Oregon – The Oregon Liquor Control Commission has released a “Business Readiness Guidebook for Oregon Recreational Marijuana Operations” for individuals interested in applying for a recreational marijuana license. The guidebook was produced under the guidance of Governor Kate Brown’s office, with contributions from more than a dozen state agencies that directly regulate the marijuana industry or regulate business.

“Obtaining a license from the OLCC is just one step to establishing a marijuana related business,” said Steve Marks, Executive Director of the OLCC. “The OLCC wants to help this industry become successful and compliant, and having this guide to help navigate the business regulatory process is an important component of that effort.”

From building codes to odor control, from waste management to workplace safety, the Business Readiness Guidebook provides an overview of the rules and requirements within the larger regulatory framework under which all businesses in Oregon must operate.

By pointing to where up-to-date state and local information can be found the OLCC expects the guide will help businesses be better prepared to establish legal recreational marijuana operations in Oregon and comply with state and local law.

The “Business Readiness Guidebook for Oregon Recreational Marijuana Operations” can be found on the OLCC website and will be updated with current information as it becomes available.

(Keshena, WI) –Today, Federal Agents improperly and unnecessarily entered the sovereign lands of the Menominee Indian Tribe of Wisconsin and destroyed the Tribe’s industrial hemp crop.

In May 2015, the Menominee Indian Tribe of Wisconsin Tribe legalized the growing of low THC non-psychotropic industrial hemp by Tribal licensees on its lands. Notice of this change in Tribal law was provided to the United States Attorney Office for the Eastern District of Wisconsin. This action was intended to comply with Congress’s actions in 2014 Farm Bill which recognizing a distinction between marijuana and industrial hemp that created an exception to the Controlled Substance Act to allow for growth, cultivation and the study of industrial hemp in certain circumstances. The Tribe’s industrial hemp crop was always intended to be a legal crop as allowed by the 2014 Farm Bill.